Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Jopson

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Canadian Journal of Gastroenterology & Hepatology|December 16, 2022
Neurosteroid Activation of GABA-A Receptors: A Potential Treatment Target for Symptoms in Primary Biliary Cholangitis?Aaron Wetten, Laura Ogle, George Mells, et al.
Journal of Translational Autoimmunity|February 8, 2021
Quality of life in patients with primary biliary cholangitis: A cross-geographical comparisonLorenzo Montali, Andrea Gragnano, Massimo Miglioretti, et al.
Hepatology (Baltimore, Md.)|June 15, 2021
The Serum Proteome and Ursodeoxycholic Acid Response in Primary Biliary CholangitisBen Barron-Millar, Laura Ogle, George Mells, et al.
Ebiomedicine|May 24, 2022
The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort studyDavid E J Jones, Aaron Wetten, Ben Barron-Millar, et al.
The American Journal of Pathology|October 15, 2022
Anti-Cholestatic Therapy with Obeticholic Acid Improves Short-Term Memory in Bile Duct-Ligated MiceLucy M V Gee, Ben Barron-Millar, Jack Leslie, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Canadian Journal of Gastroenterology & Hepatology|December 16, 2022
Neurosteroid Activation of GABA-A Receptors: A Potential Treatment Target for Symptoms in Primary Biliary Cholangitis?Aaron Wetten, Laura Ogle, George Mells, et al.
Journal of Translational Autoimmunity|February 8, 2021
Quality of life in patients with primary biliary cholangitis: A cross-geographical comparisonLorenzo Montali, Andrea Gragnano, Massimo Miglioretti, et al.
Hepatology (Baltimore, Md.)|June 15, 2021
The Serum Proteome and Ursodeoxycholic Acid Response in Primary Biliary CholangitisBen Barron-Millar, Laura Ogle, George Mells, et al.
Ebiomedicine|May 24, 2022
The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort studyDavid E J Jones, Aaron Wetten, Ben Barron-Millar, et al.
The American Journal of Pathology|October 15, 2022
Anti-Cholestatic Therapy with Obeticholic Acid Improves Short-Term Memory in Bile Duct-Ligated MiceLucy M V Gee, Ben Barron-Millar, Jack Leslie, et al.
Pageof 2